newsfilter
← Latest News
PR Newswire·

Innocan Pharma Announces Promising Successful Results in Efficacy Trial of Diabetic Foot Relief Treatment

HERZLIYA, Israel and CALGARY, AB, Aug. 15, 2023 /CNW/ -- Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF) (the "Company" or "Innocan") a pharmaceutical technology company specializing in